Radiation to liver metastases after colon cancer treatment
Part of Cancer, Digestive system clinical trials.
This trial studies giving targeted high-dose radiation (SBRT) to liver metastases from colorectal cancer after initial treatment, with the goal of improving long-term control or cure. It may help people who have a limited number of liver spots that doctors think can be treated safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can complete consent paperwork and answer study questionnaires
- Your colon cancer treatment plan includes resection (surgery) of the original colon tumor with curative intent
- You have 1–5 liver metastases, all in one liver area (one lobe), and each spot is 5 cm or smaller
- The liver spots were found within 3 months of your original cancer diagnosis and your tumor board thinks SBRT could be used with curative intent
- You are not pregnant or breastfeeding (and if you could become pregnant, you must have a negative pregnancy test)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies stereotactic body radiation therapy (high-precision radiation given in a few sessions) for liver metastases when surgery isn’t possible. It may help shrink or control tumors in the liver and delay progression in people whose cancer has not spread outside the liver (or only to areas treated with a curative plan).
This trial combines targeted radiation (SBRT) with an immunotherapy drug (PD-1 inhibitor) to treat colorectal cancer that has spread to the liver and can't be removed by surgery. It aims to help shrink or control tumors in patients whose cancer has a normal DNA repair system (pMMR/MSS).
This trial tests a single, high-dose radiation treatment (SBRT) guided by MRI for people with colorectal cancer that has spread to the liver. The goal is to see if this precise, one-time treatment can effectively control liver tumors while protecting nearby organs.
This trial tests a combination of precise radiation to liver or lung tumors plus immunotherapy for people with advanced colorectal cancer that cannot be surgically removed. It aims to see if this approach can help control the cancer.
This trial studies a targeted liver radiation procedure that uses tiny radioactive beads to treat colon cancer spread mostly in the liver. It may help people whose liver tumors cannot be removed or treated with other common local treatments, but it has several safety and “screening” checks.
This trial tests whether focused radiation (SBRT) can treat 1 to 3 metastases in people with colorectal cancer that has spread but is still low or intermediate risk. It may be an option if you are starting first or second line systemic therapy and your primary tumor is under control.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.